Shanghai, China · Founded 2017 · Privately Held (backing)
Developer of cell immunotherapy technology designed for oncology. Huadao Biopharma is based in Shanghai, China and was founded in 2017. Its last reported valuation was $79.9 million in Jul 2019. It has raised $58.8 million.
Last reported valuation
$79.9M
Oct 2026
Priced at
—
Total raised
$58.8M
Last round
—
Cap table — not yet on record
Huadao Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Huadao Biopharma with a free account
·The complete investor list: 20 names
·Watch Huadao Biopharma: the Monday email on marks, rounds and moves
